Development, Validation, and Head-to-Head Comparison of Logistic Regression-Based Nomograms and Artificial Neural Network Models Predicting Prostate Cancer on Initial Extended Biopsy

European Urology

Volumn 54, Issue 3, 2008, Pages 601-611

  Kawakami, Satoru ^a   Numao, Noboru ^a   Okubo, Yuhei ^b   Koga, Fumitaka ^a   Yamamoto, Shinya ^b   Saito, Kazutaka ^a   Fujii, Yasuhisa ^a   Yonese, Junji ^b   Masuda, Hitoshi ^a   Kihara, Kazunori ^a   Fukui, Iwao ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Artificial neural network; Extended biopsy; Nomogram; Prediction tools; Prostate cancer; Prostate specific antigen; Validation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER CENTER; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; EXTERNAL VALIDITY; HUMAN; INTERMETHOD COMPARISON; INTERNAL VALIDITY; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NOMOGRAM; ORGAN SIZE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY ANALYSIS; TRANSRECTAL ULTRASONOGRAPHY; UNIVERSITY HOSPITAL; VALIDATION STUDY;

AGE FACTORS; AGED; BIOPSY; DIGITAL RECTAL EXAMINATION; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ROC CURVE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 47249157999     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.01.017     Document Type: Article

References (25)

1. Aus G, Abbou CC, Bolla M, et al. EAU guidelines on prostate cancer. Eur Urol 2005;48:546-51. An updated EAU guidelines on prostate cancer. Available at: http://www.uroweb.org/fileadmin/user_upload/Guidelines/07_Prostate_Cancer_2007.pdf. Accessed August 17, 2007.
2. NCCN Practice Guidelines in Oncology - Prostate Cancer Early Detection. v.2.2007. Available at: http://www.nccn.org/professionals/physician_gls/PDF/prostate_detection.pdf. Accessed July 31, 2007.
3. Stamey T.A. Making the most of six systematic sextant biopsies. Urology 45 (1995) 2-12
4. Eskew L.A., Bare R.L., and McCullough D.L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157 (1997) 199-202
5. Stewart C.S., Leibovich B.C., Weaver A.L., and Lieber M.M. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 166 (2001) 86-91
6. Kawakami S., Kihara K., Fujii Y., Masuda H., Kobayashi T., and Kageyama Y. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer. Int J Urol 11 (2004) 613-618
7. Kawakami S., Hyochi N., Yonese J., et al. Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer. Int J Clin Oncol 11 (2006) 127-132
8. Kawakami S., Okuno T., Yonese J., et al. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy. Eur Urol 51 (2007) 675-683
9. Kawakami S., Yamamoto S., Numao N., Ishikawa Y., Kihara K., and Fukui I. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Int J Urol 14 (2007) 719-724
10. Snow P.B., Smith D.S., and Catalona W.J. Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol 152 (1994) 1923-1926
11. Stephan C., Cammann H., Semjonow A., et al. Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. Clin Chem 48 (2002) 1279-1287
12. Karakiewicz P.I., Benayoun S., Kattan M.W., et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 173 (2005) 1930-1934
13. Chun F.K.-H., Briganti A., Graefen M., et al. Development and external validation of an extended 10-core biopsy nomogram. Eur Urol 52 (2007) 436-445
14. Finne P., Finne R., Bangma C., et al. Algorithms based on prostate-specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false-positive PSA results in prostate cancer screening. Int J Cancer 111 (2004) 310-315
15. Suzuki H., Komiya A., Kamiya N., et al. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients. Urology 67 (2006) 131-136
16. Walz J., Graefen M., Chun F.K.-H., et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 50 (2006) 498-505
17. Nam R.K., Toi A., Klotz L.H., et al. Assessing individual risk for prostate cancer. J Clin Oncol 25 (2007) 3582-3588
18. Bianco Jr. F.J. Nomograms and medicine. Eur Urol 50 (2006) 884-886
19. de la Taille A. Editorial comment. Eur Urol 52 (2007) 444-445
20. Kawakami S., Koga F., Yano A., et al. 22-core systematic biopsy (transperineal-14 plus transrectal-8 cores) remarkably improves prostate cancer detection over conventional sextant biopsy. J Urol 169 (2003) 435
21. Chun F.K.-H., Graefen M., Briganti A., et al. Initial biopsy outcome prediction-head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 51 (2007) 1236-1243
22. Chun F.K., Karakiewicz P.I., Briganti A., et al. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer. BJU Int 99 (2007) 794-800
23. Makarov D.V., Trock B.J., Humphreys E.B., et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 69 (2007) 1095-1101
24. Numao N., Kawakami S., Yokoyama M., et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur Urol 52 (2007) 1663-1669
25. Epstein J.I., Walsh P.C., Carmichael M., and Brendler C.B. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271 (1994) 368-374